Results 81 to 90 of about 6,693,931 (277)

Editors' Report for 2015, December 2015 [PDF]

open access: yesBritish Journal of Clinical Pharmacology, 2015
de Boer, Anthonius   +9 more
openaire   +5 more sources

O discurso de securitização da cibernética nos Estados Unidos da América no período entre 2007 e 2015 [PDF]

open access: yes, 2016
TCC (graduação) - Universidade Federal de Santa Catarina. Centro Sócio-Econômico. Relações Internacionais.A Internet global é parte integrante do nosso cotidiano.
Berwanger, Tiago
core  

Predictive Value of Composite Inflammatory Markers for Stroke Prognosis: A Prospective Cohort Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Novel composite inflammatory markers' role in stroke prognosis is understudied, and the best predictor is unclear, requiring further exploration. Objectives This study aimed to systematically evaluate the associations of 6 novel composite inflammatory markers on stroke prognosis.
Bing Wu   +7 more
wiley   +1 more source

Modern Management of Asymptomatic Carotid Stenosis: A Meta‐Analysis of CREST‐2, SPACE‐2, and ECST‐2

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Recent randomized trials (CREST‐2, SPACE‐2, and ECST‐2) have compared carotid revascularization (carotid endarterectomy [CEA] or carotid artery stenting [CAS]) plus contemporary medical therapy (CMT) versus CMT alone in asymptomatic carotid stenosis.
Aasim Ali   +14 more
wiley   +1 more source

Anti‐CD20 Discontinuation Versus Continuation in People Aged Over 50 With Non‐Active Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To determine whether discontinuing anti‐CD20 therapy in people with relapsing‐onset MS aged over 50 is associated with an increased risk of relapse, inflammatory activity, confirmed disability accrual, and serious infection compared with continuing therapy.
Alexia Moukhine   +40 more
wiley   +1 more source

Inebilizumab in AQP4‐Seropositive NMOSD: One‐Year Follow‐Up From a Multicenter, Real‐World Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Real‐world evidence on inebilizumab among neuromyelitis optica spectrum disorder (NMOSD) patients is lacking. This study assessed inebilizumab among Chinese patients with aquaporin 4 autoantibody (AQP4‐IgG)‐seropositive NMOSD in a real‐world setting.
Mengcui Gui   +10 more
wiley   +1 more source

Editorial 2015 [PDF]

open access: yesProceedings of the Royal Society B: Biological Sciences, 2015
Loren, Rieseberg   +3 more
openaire   +4 more sources

مجلة حوليات التراث العدد 15 [PDF]

open access: yesAnnales du Patrimoine, 2015
مجلة حوليات التراث، كلية الآدب والفنون، جامعة مستغانم، الجزائر، العدد 15 ...
د. محمد عباسة
doaj  

Editorial

open access: yesHolos, 2016
Este é o último volume do periódico no ano de 2015, assim se faz necessário apresentar um balanço deste ano. Com esta publicação são 220 artigos, perfazendo uma média de 27,5 artigos, por volume.
José Yvan Pereira Leite
doaj   +1 more source

The U.S. Global Change Research Program for Fiscal Year 2015: A Supplement to the President's Budget for Fiscal Year 2015 [PDF]

open access: yes, 2015
Annual report of the U.S. Global Change Research Program documenting activities and research, goals for the upcoming year, proposed budget considerations, and other information about the organization for fiscal year ...
U.S. Global Change Research Program (2009-2015)
core  

Home - About - Disclaimer - Privacy